CD22 CAR T Cell-Related IEC-HS Is Associated with an IFN-. Cytokine Signature

被引：2
|
作者：
Srinagesh, Hrishikesh [1 ]
Baird, John H. [2 ]
Agarwal, Neha [1 ]
Su, Yi-Jiun [1 ]
Kramer, Anne Marijn [3 ]
Reschke, Agnes [1 ]
Jeyakumar, Nikeshan [1 ]
Bharadwaj, Sushma [1 ]
Schultz, Liora Michal [4 ]
Ramakrishna, Sneha [5 ]
Davis, Kara L. [6 ]
Sahaf, Bita [7 ]
Feldman, Steven [3 ]
Mackall, Crystal L. [8 ]
Miklos, David B. [9 ]
Muffly, Lori S. [1 ]
Frank, Matthew J. [9 ]
机构：
[1] Stanford Univ, Div Blood & Marrow Transplantat Cellular Therapy, Sch Med, Palo Alto, CA USA
[2] City Hope Natl Med Ctr, Dept Hematol & HCT, Duarte, CA USA
[3] Stanford Univ, Ctr Canc Cell Therapy, Stanford, CA USA
[4] Stanford Univ, Div Hematol & Oncol, Dept Pediat, Sch Med, Palo Alto, CA USA
[5] Stanford Univ, Div Hematol & Oncol, Dept Pediat, Sch Med, Palo Alto, CA USA
[6] Stanford Univ, Dept Pediat Hematol Oncol & Stem Cell Transplant, Stanford, CA USA
[7] Stanford Univ, Canc Correlat Sci Unit, Palo Alto, CA USA
[8] Stanford Univ, Stanford Canc Inst, Ctr Canc Cell Therapy, Stanford, CA USA
[9] Stanford Univ, Div Blood & Marrow Transplantat Cellular Therapy, Palo Alto, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-178283
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Outcomes of patients who received CAR T cell therapy and developed IEC-HS treated with cytokine directed therapy.
    Leung, Nelson
    Alkhateeb, Hassan B.
    Atallah-Yunes, Suheil Albert
    Durani, Urshila
    De Moraes, Alice Gallo
    Gupta, Supriya
    Hayman, Suzanne R.
    Herrmann, Joerg
    Johnston, Patrick B.
    Kenderian, Saad
    Khurana, Arushi
    Puttkammer, Jenna R.
    Matthew, Rees J.
    Sandahl, Tyler B.
    Vergidis, Paschalis
    Warsame, Rahma M.
    Wolf, Robert C.
    Lin, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Sequential CD22 Targeting Impacts CD22 CAR-T Cell Response
    Yates, Bonnie
    Shalabi, Haneen
    Salem, Dalia
    Delbrook, Cynthia
    Yuan, Constance M.
    Stetler-Stevenson, Maryalice
    Fry, Terry J.
    Shah, Nirali N.
    BLOOD, 2018, 132
  • [3] Transcriptional Profiling Associated with CD22 CAR T Cell Clinical Response in LBCL
    Kramer, Anne Marijn
    Hamilton, Mark P.
    Prabhu, Snehit
    Desai, Moksha
    Kuo, Adam
    Ehlinger, Zachary
    Agarwal, Neha
    Su, Yi-Jiun
    Gkitsas, Nikolaos
    Fowler, Carley
    Keerthi, Vimal
    Retherford, Aidan
    Klysz, Dorota
    Tunuguntla, Ramya
    Feldman, Steven
    Sahaf, Bita
    Baird, John H.
    Muffly, Lori S.
    Mackall, Crystal L.
    Miklos, David B.
    Good, Zinaida
    Frank, Matthew J.
    BLOOD, 2023, 142
  • [4] CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity
    Jess, Jennifer
    Yates, Bonnie
    Dulau-Florea, Alina
    Parker, Kevin
    Inglefield, Jon
    Lichtenstein, Dan
    Schischlik, Fiorella
    Ongkeko, Martin
    Wang, Yanyu
    Shahani, Shilpa
    Cullinane, Ann
    Smith, Hannah
    Kane, Eli
    Little, Lauren
    Chen, Dong
    Fry, Terry J.
    Shalabi, Haneen
    Wang, Hao-Wei
    Satpathy, Ansuman
    Lozier, Jay
    Shah, Nirali N.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (06)
  • [5] Phase I CD22 CAR T-cell trial updates
    Shah, Nirali N.
    Shalabi, Haneen
    Yates, Bonnie
    Yuan, Constance
    Qin, Haiying
    Ombrello, Amanda
    Wang, Hao-Wei
    Hoffman, Leah
    Minh Tran
    Panch, Sandhya
    Stetler-Stevenson, Maryalice
    Jin, Jianjian
    Mackall, Crystal
    Highfill, Steve
    Stroncek, David
    Fry, Terry J.
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and yδ T cell output
    Song, Hannah W.
    Benzaoui, Mehdi
    Dwivedi, Alka
    Underwood, Sarah
    Shao, Lipei
    Achar, Sooraj
    Posarac, Vesna
    Remley, Victoria A.
    Prochazkova, Michaela
    Cai, Yihua
    Jin, Ping
    Somerville, Robert P.
    Stroncek, David F.
    Altan-Bonnet, Gregoire
    Shah, Nirali N.
    Chien, Christopher D.
    Taylor, Naomi
    Highfill, Steven L.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)
  • [7] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
    Jing Pan
    Qing Niu
    Biping Deng
    Shuangyou Liu
    Tong Wu
    Zhiyong Gao
    Zhaoli Liu
    Yue Zhang
    Xiaomin Qu
    Yanlei Zhang
    Shaohui Liu
    Zhuojun Ling
    Yuehui Lin
    Yongqiang Zhao
    Yanzhi Song
    Xiyou Tan
    Yan Zhang
    Zhihui Li
    Zhichao Yin
    Bingzhen Chen
    Xinjian Yu
    Ju Yan
    Qinlong Zheng
    Xuan Zhou
    Jin Gao
    Alex H. Chang
    Xiaoming Feng
    Chunrong Tong
    Leukemia, 2019, 33 : 2854 - 2866
  • [8] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
    Pan, Jing
    Niu, Qing
    Deng, Biping
    Liu, Shuangyou
    Wu, Tong
    Gao, Zhiyong
    Liu, Zhaoli
    Zhang, Yue
    Qu, Xiaomin
    Zhang, Yanlei
    Liu, Shaohui
    Ling, Zhuojun
    Lin, Yuehui
    Zhao, Yongqiang
    Song, Yanzhi
    Tan, Xiyou
    Zhang, Yan
    Li, Zhihui
    Yin, Zhichao
    Chen, Bingzhen
    Yu, Xinjian
    Yan, Ju
    Zheng, Qinlong
    Zhou, Xuan
    Gao, Jin
    Chang, Alex H.
    Feng, Xiaoming
    Tong, Chunrong
    LEUKEMIA, 2019, 33 (12) : 2854 - 2866
  • [9] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
    Jing, P.
    Niu, Q.
    Deng, B.
    Liu, S.
    Wu, T.
    Gao, Z.
    Chang, A. H.
    Feng, X.
    Tong, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1723 - 1723
  • [10] Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
    Phely, Laurent
    Hensen, Luca
    Faul, Christoph
    Ruff, Christer Alexander
    Schneider, Dina
    Bethge, Wolfgang Andreas
    Lengerke, Claudia
    JAMA ONCOLOGY, 2024, 10 (06) : 821 - 824
12345